
NeuBase Therapeutics NBSE
Quarterly report 2023-Q3
added 11-09-2023
NeuBase Therapeutics Historical Prices 2011-2026 | NBSE
Annual Historical Prices NeuBase Therapeutics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.19 | 1.52 | 9.15 | 6.37 | 2.68 | 6.36 | 29 | 78.6 | 150 | 205 | 101 | 38.4 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 205 | 0.19 | 52.4 |
Historical Prices of other stocks in the Biotechnology industry
| Issuer | Historical Prices | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
18.2 | - | 2.43 % | $ 254 M | ||
|
ARCA biopharma
ABIO
|
28.8 | - | 1052.0 % | $ 415 M | ||
|
Acasti Pharma
ACST
|
3.37 | - | 4.01 % | $ 150 M | ||
|
AC Immune SA
ACIU
|
1.98 | $ 2.72 | 7.51 % | $ 229 M | ||
|
Adverum Biotechnologies
ADVM
|
3.86 | - | - | $ 86.2 M | ||
|
AgeX Therapeutics
AGE
|
13 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
12 | - | - | $ 1.01 B | ||
|
AIkido Pharma
AIKI
|
3.17 | - | 1.93 % | $ 17.4 M | ||
|
Aptorum Group Limited
APM
|
0.75 | $ 0.81 | 1.28 % | $ 4.42 M | ||
|
I-Mab
IMAB
|
0.68 | - | - | $ 866 M | ||
|
argenx SE
ARGX
|
615 | $ 840.28 | 1.7 % | $ 25 B | ||
|
Ascendis Pharma A/S
ASND
|
216 | $ 234.99 | 0.02 % | $ 5 B | ||
|
Akero Therapeutics
AKRO
|
48.4 | - | - | $ 3.67 B | ||
|
Biophytis SA
BPTS
|
0.33 | - | -13.47 % | $ 169 M | ||
|
Albireo Pharma
ALBO
|
28.5 | - | -0.23 % | $ 916 M | ||
|
Alterity Therapeutics Limited
ATHE
|
0.58 | $ 3.33 | 0.79 % | $ 8.01 B | ||
|
Atea Pharmaceuticals
AVIR
|
3.02 | $ 4.65 | 1.31 % | $ 392 M | ||
|
Allena Pharmaceuticals
ALNA
|
0.383 | - | 3.16 % | $ 1.9 M | ||
|
AlloVir
ALVR
|
9.78 | - | 4.14 % | $ 49.1 M | ||
|
Midatech Pharma plc
MTP
|
0.29 | - | -18.52 % | $ 27.3 M | ||
|
Akouos
AKUS
|
5.34 | - | 0.23 % | $ 488 M | ||
|
BioVie
BIVI
|
1.65 | $ 1.25 | - | $ 1.85 M | ||
|
Ampio Pharmaceuticals
AMPE
|
0.82 | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
0.57 | - | - | $ 10.1 M | ||
|
BioMarin Pharmaceutical
BMRN
|
69 | $ 62.62 | -0.48 % | $ 11.9 B | ||
|
Acorda Therapeutics
ACOR
|
13.5 | - | -24.86 % | $ 820 K | ||
|
Acer Therapeutics
ACER
|
0.77 | - | 2.71 % | $ 14 M | ||
|
Aravive
ARAV
|
1.66 | - | -13.39 % | $ 1.45 M | ||
|
Capricor Therapeutics
CAPR
|
5.8 | $ 27.91 | 0.14 % | $ 747 M | ||
|
CASI Pharmaceuticals
CASI
|
8.4 | $ 0.8 | 5.68 % | $ 109 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.3 | - | - | $ 26.5 M | ||
|
Avenue Therapeutics
ATXI
|
0.42 | - | -52.27 % | $ 4.45 M | ||
|
Catalyst Biosciences
CBIO
|
0.51 | $ 12.65 | 10.29 % | $ 833 M | ||
|
Axsome Therapeutics
AXSM
|
174 | $ 169.95 | -2.75 % | $ 8.45 B | ||
|
Ayala Pharmaceuticals
AYLA
|
0.5 | - | - | $ 7.46 M | ||
|
Atreca
BCEL
|
1.27 | - | -11.76 % | $ 5.79 M | ||
|
Alpine Immune Sciences
ALPN
|
8.04 | - | - | $ 2.17 B | ||
|
BioDelivery Sciences International
BDSI
|
3.1 | - | -4.8 % | $ 255 M | ||
|
Aeterna Zentaris
AEZS
|
5.72 | - | 5.93 % | $ 314 M | ||
|
BeiGene, Ltd.
BGNE
|
185 | - | 0.49 % | $ 251 B | ||
|
Biogen
BIIB
|
201 | $ 195.13 | -0.62 % | $ 28.6 B | ||
|
Cellectis S.A.
CLLS
|
1.27 | $ 3.98 | 0.51 % | $ 116 M | ||
|
Bellicum Pharmaceuticals
BLCM
|
0.27 | - | -9.72 % | $ 5.89 M | ||
|
Baudax Bio
BXRX
|
2.35 | - | 0.59 % | $ 63 K | ||
|
Aptose Biosciences
APTO
|
3.32 | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
0.14 | - | -39.0 % | $ 4.57 M | ||
|
Cellectar Biosciences
CLRB
|
3.64 | $ 3.36 | 3.07 % | $ 41.1 M |